Discontinued — last reported Q2 '22
Business Segments · Revenue
Medical — Revenue
Becton, Dickinson and Company Medical — Revenue decreased by 10.2% to $4.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $4.48B to $4.71B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ3 2015
Last reportedQ2 2022
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market share or higher demand for medical supplies, while a decrease may signal competitive pressure or reduced healthcare utilization.
Detailed definition
Represents the total gross sales generated by the medical products business segment, including needles, syringes, and sh...
Peer comparison
Standard revenue reporting for medical device segments across peers like Medtronic or Baxter.
Metric ID:
bdx_segment_medical_revenuesHistorical Data
38 periods
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.61B | $2.38B | $4.30B | $2.53B | $4.72B | $2.40B | $4.75B | $2.42B | $4.64B | $2.19B | $4.76B | $1.84B | $4.59B | $2.15B | $4.82B | $2.36B | $4.88B | $2.43B | $5.09B | $2.55B | $4.71B | $2.23B | $5.05B | $2.45B | $4.99B | $2.56B | $5.44B | $2.84B | $5.17B | $2.62B | $4.48B | $2.76B | $5.51B | $2.93B | $6.68B | $3.15B | $5.25B | $4.71B |
| QoQ Change | — | -48.4% | +81.1% | -41.1% | +86.3% | -49.2% | +98.2% | -49.1% | +92.1% | -52.8% | +117.3% | -61.4% | +149.6% | -53.0% | +123.8% | -51.0% | +106.7% | -50.1% | +109.0% | -49.8% | +84.3% | -52.6% | +126.2% | -51.5% | +103.8% | -48.7% | +112.5% | -47.8% | +82.2% | -49.4% | +71.3% | -38.4% | +99.6% | -46.9% | +128.3% | -52.8% | +66.5% | -10.2% |
| YoY Change | — | — | — | — | — | — | — | — | +0.7% | -52.4% | +10.7% | -57.3% | -2.8% | -54.3% | +1.5% | -50.3% | +5.1% | -47.6% | +6.8% | -46.4% | +2.6% | -51.4% | +4.6% | -49.2% | +2.3% | -47.6% | +6.9% | -44.2% | +9.8% | -44.4% | -11.2% | -45.3% | +10.4% | -41.3% | +22.9% | -42.0% | +1.6% | +5.2% |
Range$1.84B – $6.68B
CAGR+0.2%
Avg YoY Growth-19.9%
Median YoY Growth-7.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical — revenue?
- Becton, Dickinson and Company (BDX) reported medical — revenue of $4.71B in Q1 2026.
- How has Becton, Dickinson and Company's medical — revenue changed year-over-year?
- Becton, Dickinson and Company's medical — revenue increased by 5.2% year-over-year, from $4.48B to $4.71B.
- What does medical — revenue mean?
- Total revenue generated by the medical products business segment.